BioSpace News Archive

Business

Cytokinetics Reports First Quarter 2024 Financial Results

Cytokinetics, Incorporated reported financial results for the first quarter of 2024. Net loss for the first quarter was $135.6 million, or $1.33 per share, compared to net loss for the first quarter of 2023 of $131.3 million, or $1.38 per share.

May 8, 2024
·
13 min read
BioMidwest

Pacira BioSciences, Inc. Announces Proposed Offering of $250.0 Million Aggregate Principal Amount of Convertible Senior Notes

Pacira BioSciences, Inc. announced that it intends to offer, subject to market and other conditions, $250.0 million aggregate principal amount of convertible senior notes due 2029 in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

May 8, 2024
·
7 min read
Biotech Beach

RxSight, Inc. Announces Proposed Public Offering of Common Stock - May 08, 2024

RxSight, Inc. announced that it intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering.

May 8, 2024
·
4 min read
Business

Vanda Pharmaceuticals Reports First Quarter 2024 Financial Results

Vanda Pharmaceuticals Inc. announced financial and operational results for the first quarter ended March 31, 2024.

May 8, 2024
·
16 min read
Biotech Beach

Avidity Biosciences to Participate in Upcoming May 2024 Investor Conference

Avidity Biosciences, Inc., a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, announced that Avidity management will be participating in the following upcoming conference:

May 8, 2024
·
1 min read
Genetown

Karyopharm to Participate at the 2024 RBC Capital Markets Global Healthcare Conference

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, announced that the Company’s senior management team will participate at the 2024 RBC Capital Markets Global Healthcare Conference in a fireside chat on Wednesday, May 15 at 9:30 a.m. ET.

May 8, 2024
·
1 min read
Business

Mirum Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update

Mirum Pharmaceuticals, Inc. reported financial results for first quarter 2024 and provided a business update.

May 8, 2024
·
13 min read
Business

Arcus Biosciences Reports First-Quarter 2024 Financial Results and Provides a Pipeline Update

Arcus Biosciences, Inc. reported financial results for the first quarter ended March 31, 2024, and provided a pipeline update on its clinical-stage investigational molecules – targeting TIGIT, the adenosine axis, HIF-2a, AXL and PD-1 – across multiple common cancers.

May 8, 2024
·
15 min read
Business

ChromaDex Corporation Reports First Quarter 2024 Financial Results

ChromaDex Corp. announced financial results for the first quarter of 2024.

May 8, 2024
·
13 min read
Bio NC

Dentsply Sirona to Participate in Upcoming May 2024 Investor Conferences

DENTSPLY SIRONA Inc. announced its participation at upcoming conferences.

May 8, 2024
·
1 min read